Eterna Therapeutics
ERNA
ERNA
18 hedge funds and large institutions have $2.51M invested in Eterna Therapeutics in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$148K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$7K |
| 3 |
3
Barclays
London,
United Kingdom
|
$1K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$144K |
Top Sellers
| 1 |
MHP
1
Manatuck Hill Partners
Westport,
Connecticut
|
$95K |
| 2 |
2
Goldman Sachs
New York
|
$123K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$92K |
| 4 |
4
JPMorgan Chase & Co
New York
|
$0 |
